Maynard Um
-
-
-
-
-
-
-
Inhibrx Biosciences (INBX) Reiterated at Buy by Stifel After Ozekibart Data Presentation
-
-
-
-
-
-
-
Stifel Starts Inhibrx Biosciences (INBX) at Buy, $150 PT
-
-
-
-
-
-
-
Citizens JMP Reiterates Market Perform Rating on Inhibrx Biosciences (INBX)
-
-
-
-
-
-
-
Inhibrx Inc. (INBX) Announces Loan Agreement with Oxford Finance
-
-
-
443,654 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

